Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
40%
Ph phase_4
1
20%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(2)
Other(1)

Detailed Status

Completed2
Not yet recruiting1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 32 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

completed240%
not_yet_recruiting120%
recruiting120%
unknown120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingphase_4

Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment

NCT03868150
not_yet_recruitingnot_applicable

Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation

NCT06742866
completed

AMSA and Amiodarone Study in Cardiac Arrest

NCT04997980
unknownphase_3

Prophylactic Amiodarone for Shockable Cardiac Arrest

NCT04845607
completedphase_3

A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation

NCT00668759

Clinical Trials (5)

Showing 5 of 5 trials
NCT03868150Phase 4

Prevention of Postop Atrial Fibrillation Through Intraoperative Inducibility of Atrial Fibrillation and Amiodarone Treatment

Recruiting
NCT06742866Not Applicable

Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation

Not Yet Recruiting
NCT04997980

AMSA and Amiodarone Study in Cardiac Arrest

Completed
NCT04845607Phase 3

Prophylactic Amiodarone for Shockable Cardiac Arrest

Unknown
NCT00668759Phase 3

A Phase III Superiority Study of Vernakalant vs Amiodarone in Subjects With Recent Onset Atrial Fibrillation

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5